Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2022
Source ID
10.1016/j.exer.2022.108966

Entities

People

  • Aaron M. Perry
  • Anton Reiner
  • Bob M. Moore
  • Chunyan Li
  • Desmond L. Henderson
  • Dylan O'neal
  • Marcia G. Honig
  • Meghna Yammanur
  • Nobel A. Del Mar
  • Rachel Cox

Organizations

  • National Eye Institute
  • United States Department of Defense